1093.HK vs LCLA: Side-by-Side Comparison
Compare CSPC Pharmaceutical Group Limited (1093.HK) and PT Kalbe Farma Tbk (LCLA) side by side: market cap HKD 79.50B vs EUR 2.13B. Financials, growth and model signals on Bullrun.
| Metric | 1093.HK | LCLA |
|---|---|---|
| Company | CSPC Pharmaceutical Group Limited | PT Kalbe Farma Tbk |
| Country / Exchange | Hong Kong | Indonesia · F |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Market cap | HKD 79.50B | EUR 2.13B |
| P/E ratio | 17.9 | — |
| Dividend yield | 4.20% | 2.93% |
| Valuation model | — | — |
| Revenue (latest FY) | HKD 26.01B | — |
| Revenue growth YoY | -10.4% | — |
| Net income | HKD 3.88B | — |
| Gross margin | 65.6% | — |
| Diluted EPS | 0.34 | — |